Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » FDA clears Gore’s Cardioform ASD occluder

FDA clears Gore’s Cardioform ASD occluder

By

Gore

W.L. Gore & Associates said today that it won FDA premarket approval for its Gore Cardioform ASD occluder designed for the percutaneous closure of ostium secundum atrial septal defects.

Approval came supported by data from the pivotal stage of Flagstaff, Ariz.-based Gore’s ASSURED clinical study, which reported a 100% closure success rate at six months post-implant.

Investigators in the ASSURED trial explored the safety and efficacy of atrial septal defects using the Cardioform ASD occluder in 125 patients with evidence of right heart volume overload demonstrating the need for defect closure. The trial met its safety, closure and technical success primary endpoints, Gore said.

“The FDA approval of the Gore Cardioform ASD occluder is a significant milestone for innovation in the minimally invasive treatment of ASDs. This soft, conformable device was not previously available for this range of defects but is now an option for larger defects that typically have a greater risk for complications, including right heart enlargement, atrial fibrillation, and pulmonary hypertension. The ability to retrieve and reposition the Gore Cardioform ASD occluder helps me ensure proper positioning and offers me confident closure,” co-principal trial investigator Dr. Matthew Gillespie of the Children’s Hospital of Philadelphia said in a prepared statement.

The Gore Cardioform ASD occluder features an adaptable waist to conform to the defect to close ASDs of between 8mm to 35mm in diameter, including those without a retro-aortic rim. The system is designed to facilitate optimal tissue ingrowth and maintain thromboresistance, Gore said.

“We developed the Gore Cardioform ASD occluder in partnership with leading interventional cardiologists around the globe, and its design is informed by decades of experience in technological innovation and dedication to improving patient care. This new addition extends what physicians can achieve with the Gore Cardioform occluder family,” Gore structural heart pipeline leader Jake Goble said in a prepared release.

Last month, Gore said that it won a nod from the FDA for its Gore Tag conformable thoracic endovascular aortic repair stent graft with Active Control.

In case you missed it

RSS From Medical Design & Outsourcing

  • Resonant Link and Cirtec partner on implantable medical devices
    Resonant Link and Cirtec Medical have entered into a strategic partnership to serve developers of implantable medical devices. The two medtech suppliers said today that the partnership will combine Resonant Link’s next-generation wireless power technology with Cirtec Medical’s product design, development and manufacturing expertise to “offer medical device makers the best technology, fully integrated components,… […]
  • Johnson & Johnson MedTech plans manufacturing facility in Costa Rica
    Johnson & Johnson MedTech will build a 200,000-sf² manufacturing facility in Alajuela, Costa Rica, the medical device developer said today. It’s the largest investment J&J MedTech has ever made outside the U.S., according to Procomer, the agency that promotes Costa Rican exports. J&J MedTech — Johnson & Johnson’s medical device business, which by itself is… […]
  • The secret behind Intuitive’s surgical robotics success
    Intuitive Surgical has pioneered robotic surgery since the 1990s, continuously driving innovation and collaboration through data to advance patient care. Teamwork between surgeons and engineers has been a crucial factor behind Intuitive developing effective surgical platforms that solve real-world problems that surgeons face. Multibillion-dollar companies including Medtronic and Johnson & Johnson — and smaller up-and-comers… […]
  • 3D-printed ventricles made from fiber-infused gel ink mimic heartbeats
    Researchers have found a way to use fiber-infused ink to 3D-print a functional heart ventricle that mimics the beating of a human heart. The team included researchers from Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and the Wyss Institute for Biologically Inspired Engineering at Harvard University. They reported on their new… […]
  • Synchron’s plan to beat Neuralink in the neuroprosthetic BCI race
    Competing brain-computer interface (BCI) developers Synchron and Neuralink both announced big news this month as they move their dueling neuroimplant technologies forward. The device developers each have FDA investigational device exemption (IDE) for their experimental BCIs. They’ve also got billionaires backing their R&D and regulatory efforts, with Neuralink owned by Elon Musk and Synchron funded… […]
  • How LimFlow’s foot-saving system prevents amputations in patients with no other options
    LimFlow’s breakthrough system for treating chronic limb-threatening ischemia (CLTI) is the first of its kind approved by the FDA for this severe form of peripheral artery disease (PAD). For CLTI patients who have lost blood flow below their knee and have no other suitable endovascular or surgical treatment options available, the LimFlow System for Transcatheter… […]
  • Device strategies to prevent healthcare-associated infections
    Device design, sterilization before use and proper cleaning of reusable equipment can prevent infections and save lives. By Ted Eveleth, AvantGuard Nosocomial infections, also commonly known as healthcare-associated infections (HAIs), are a multibillion-dollar problem and a leading cause of morbidity and mortality around the world. On any given day, about 1 in 31 hospital patients… […]
  • MGS breaks ground on innovation and tech center
    MGS has started construction of its new innovation center at its headquarters campus in Germantown, Wisconsin. The medtech contract manufacturer said the 120,000 ft² facility is scheduled to open by the end of 2024. The MGS expansion will have collaborative workspaces dedicated to ideation and product development, tooling development, automation, and part and process validation,… […]
  • Two-armed surgical robot prototype targets pediatric brain tumors
    Researchers say they’ve developed a surgical robot for removing brain tumors in children, and that it could also offer a less invasive, safer option for adult neurosurgery and other procedures. The trick is using hollow, nitinol robot arms to allow neurosurgeons to swap tools during a tumor resection procedure, said Pierre DuPont. He’s the chief… […]
  • S3 Connected Health joins DiMe’s International Regulatory Pathways project
    NEWS RELEASE: S3 Connected Health joins DiMe’s team of digital health experts in their new project ‘International Regulatory Pathways’ DUBLIN, September 19, 2023 – Building on the success of the Digital Health US Regulatory Pathways, DiMe has assembled a global team of digital health experts, including S3 Connected Health, to support digital health product developers… […]
  • Four steps medtech startups can’t put off
    Developing and commercializing a new medical device is a success worth toasting for medtech startups — but that success also makes it more likely that litigation is in their future. There are steps medtech startups can take to protect themselves down the road, said Greenberg Traurig shareholder Ginger Pigott, a litigator who defends major medical… […]

Copyright © 2023 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy